Literature DB >> 20872888

Novel single-platform multiparameter FCM analysis of apoptosis: Significant differences between wash and no-wash procedure.

Julia Stemberger1, Volker Witt, Dieter Printz, René Geyeregger, Gerhard Fritsch.   

Abstract

FCM is a generally accepted tool to analyze apoptosis. Unfortunately, the cell preparation of all commercial kits available includes cell washing known to cause cell loss which is most likely to affect apoptotic cells in particular. To address this, we developed a seven-color single-platform no-wash analysis technique and compared the results with those from an analogous procedure including cell washing. A five-color mAb cocktail was employed to address target cells by surface labeling, Yo-PRO-1® and DAPI were used to discriminate apoptotic and necrotic from viable cells. Cells were quantified on the basis of internal-standard fluorescent beads. Jurkat cells ACC 282 treated with camptothecin were employed to establish the staining procedure, which was then applied to blood cells collected by extracorporeal apheresis and treated with UV irradiation. Data evaluation showed that although each method by itself was highly reproducible (R(2) = 0.973), the numbers of apoptotic cells detected with the no-wash procedure were significantly higher than those obtained after cell washing (P = 6.6 E(-5), Wilcoxon Test). In addition, the observed differences increased with higher cell numbers (Bland and Altmann). We conclude that the described test is a feasible and reliable tool for apoptosis measurement and it provides results that are definitely closer to the truth than those obtained from kits that require cell washing.
© 2010 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872888     DOI: 10.1002/cyto.a.20976

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  4 in total

1.  Discovery and antitumor activities of constituents from Cyrtomium fortumei (J.) Smith rhizomes.

Authors:  Shengjie Yang; Mingchuan Liu; Na Liang; Qi Zhao; Yuping Zhang; Wei Xue; Song Yang
Journal:  Chem Cent J       Date:  2013-02-04       Impact factor: 4.215

2.  The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.

Authors:  Dagmar Schinnerl; Klaus Fortschegger; Maximilian Kauer; João R M Marchante; Reinhard Kofler; Monique L Den Boer; Sabine Strehl
Journal:  Blood       Date:  2014-12-16       Impact factor: 22.113

3.  Drug Discovery Testing Compounds in Patient Samples by Automated Flow Cytometry.

Authors:  Pilar Hernández; Julián Gorrochategui; Daniel Primo; Alicia Robles; José Luis Rojas; Ana Belén Espinosa; Cristina Gómez; Joaquín Martínez-López; Teresa A Bennett; Joan Ballesteros
Journal:  SLAS Technol       Date:  2017-03-24       Impact factor: 3.047

4.  Buyang Huanwu Decoction fraction protects against cerebral ischemia/reperfusion injury by attenuating the inflammatory response and cellular apoptosis.

Authors:  Yulian Jin; Liuyi Dong; Changqing Wu; Jiang Qin; Sheng Li; Chunyan Wang; Xu Shao; Dake Huang
Journal:  Neural Regen Res       Date:  2013-01-25       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.